CoChat

Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study

Open access
Bach, Simon P, Gilbert, Alexandra, Brock, Kristian, Korsgen, Stephan, Geh, Ian, Hill, James, Gill, Talvinder, Hainsworth, Paul, Tutton, Matthew G, Khan, Jim, Robinson, Jonathan, Steward, Mark, Cunningham, Christopher, Levy, Bruce, Beveridge, Alan, Handley, Kelly, Kaur, Manjinder, Marchevsky, Natalie, Magill, Laura, Russell, Ann, Quirke, Philip, West, Nicholas P, Sebag-Montefiore, David, Brown, Gina, Antonio, Peter, Vince, Alex, Hilken, Nick, Sidile, Chakanaka, Wilcockson, Adrian, Peto, Richard, Crosby, Tom, Moran, Brendan, Olliff, Julie, Ashok, Katti, Slawik, Simone, Smethurst, Andrew, Sripadam, Rajaram, Tagore, Veena, Terlizzo, Monica, Philip, Bearn, Davies, Robert, Dodd, Susan, Essapen, Sharadah, Nisar, Pasha, Stewart, Alexandra, Trickett, Jonathan, Ashish, Bansal, Billings, Peter, Chandran, Palanichamy, Corr, Conor, Favill, Edward, Gollins, Simon, Marsh, Peter, Maw, Andrew, Neupane, Rakha, Rajagopal, Ramesh, Cooper, Rachel, Griffith, John, Hatfield, Paul, Lowe, Andy, Ostrowski, Julian, Robinson, Jonathan, Simpson, Rhian, Adams, Richard, Bleehen, Robert, Davies, Michael, Morgan, Meleri, Boone, Darren, Lacey, Nicola, Seddon, Ian, Sizer, Bruce, Stunell, Helen, Wu, Shaobin, Hadaki, Maher, Blunt, Dominic, Cleator, Susan, Darzi, Ara, Goldin, Robert, Ziprin, Paul, Dobson, Mike, Pitt, Mark, Susnerwala, Shabbir, Williamson, Deborah, Howarth, Georgina, Lee, Stephen, Wright, Paul, Hoare, Tim, Horgan, Alan, McDonald, Fiona, Needham, Stephanie, Scott, John, Simmons, Timothy, Biswas, Debashis, Hernon, James, Kapur, Gaurav, Kapur, Sandeep, Sington, James, Speakman, Christopher, Stebbings, William, Williams, Stuart, Adusumalli, Madhavi, Agarwal, Anil, Borowski, David, Garg, Dharmendra, Gill, Talvinder, Hegab, Mohammed, Hobday, Catherine, Rao, Veena, Shrimankar, Jyotsna, Tabaqchali, Mohamed, Wilson, David, Jones, Oliver, Mortensen, Neil, Slater, Andrew, Szuts, Aron, Wang, Lai, Warren, Bryan, Weaver, Andrew, Ahmad, Mukhtar, Alexander, Julian, Flubacher, Maxine, Tarver, David, Baluch, Suhail, Beable, Richard, Cowlishaw, David, Higginson, Antony, Vogiatzis, Prokopios, Cruickshank, Neil, Joy, Howard, Peake, David, Zanetto, Ulises, Saunders, Mark, Sun-Myint, Arthur, Sripadam, Rajaram, Cooper, Rachel, Hatfield, Paul, Teo, Mark, Allan, Arthur, Geh, Ian, Glaholm, John, Goldstein, Mark, Hejmadi, Rahul, Langman, Gerald, Morton, Dion, Nelson, Cyril, Tattersall, Deborah, Falk, Stephen, Longman, Robert, Roach, Huw, Shabbir, Jamshed, Shelley-Fraser, Golda, Thomas, Michael, Cripps, Neil, Haba, Yasser, Harris, Guy, Hookway, Max, Simson, Jay, Skull, Angela, Umar, Tijani · 2021 · The Lancet Gastroenterology & Hepatology
Cited by 197

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background Radical surgery via total mesorectal excision might not be the optimal first-line treatment for early-stage rectal cancer. An organ-preserving strategy with selective total mesorectal excision could reduce the adverse effects of treatment without substantially compromising oncological outcomes. We investigated the feasibility of recruiting patients to a randomised trial comparing an organ-preserving strategy with total mesorectal excision. Methods TREC was a randomised, open-label feasibility study done at 21 tertiary referral centres in the UK. Eligible participants were aged 18 years or older with rectal adenocarcinoma, staged T2 or lower, with a maximum diameter of 30 mm or less; patients with lymph node involvement or metastases were excluded. Patients were randomly allocated (1:1) by use of a computer-based randomisation service to undergo organ preservation with short-course radiotherapy followed by transanal endoscopic microsurgery after 8–10 weeks, or total mesorectal excision. Where the transanal endoscopic microsurgery specimen showed histopathological features associated with an increased risk of local recurrence, patients were considered for planned early conversion to total mesorectal excision. A non-randomised prospective registry captured patients for whom randomisation was considered inappropriate, because of a strong clinical indication for one treatment group. The primary endpoint was cumulative randomisation at 12, 18, and 24 months. Secondary outcomes evaluated safety, efficacy, and health-related quality of life assessed with the European Organisation for Research and Treatment of Cancer (EORTC) QLQ C30 and CR29 in the intention-to-treat population. This trial is registered with the ISRCTN Registry, ISRCTN14422743. Findings Between Feb 22, 2012, and Dec 19, 2014, 55 patients were randomly assigned at 15 sites; 27 to organ preservation and 28 to radical surgery. Cumulatively, 18 patients had been randomly assigned at 12 months, 31 at 18 months, and 39 at 24 months. No patients died within 30 days of initial treatment, but one patient randomly assigned to organ preservation died within 6 months following conversion to total mesorectal excision with anastomotic leakage. Eight (30%) of 27 patients randomly assigned to organ preservation were converted to total mesorectal excision. Serious adverse events were reported in four (15%) of 27 patients randomly assigned to organ preservation versus 11 (39%) of 28 randomly assigned to total mesorectal excision (p=0·04, χ 2 test). Serious adverse events associated with organ preservation were most commonly due to rectal bleeding or pain following transanal endoscopic microsurgery (reported in three cases). Radical total mesorectal excision was associated with medical and surgical complications including anastomotic leakage (two patients), kidney injury (two patients), cardiac arrest (one patient), and pneumonia (two patients). Histopathological features that would be considered to be associated with increased risk of tumour recurrence if observed after transanal endoscopic microsurgery alone were present in 16 (59%) of 27 patients randomly assigned to organ preservation, versus 24 (86%) of 28 randomly assigned to total mesorectal excision (p=0·03, χ 2 test). Eight (30%) of 27 patients assigned to organ preservation achieved a complete response to radiotherapy. Patients who were randomly assigned to organ preservation showed improvements in patient-reported bowel toxicities and quality of life and function scores in multiple items compared to those who were randomly assigned to total mesorectal excision, which were sustained over 36 months' follow-up. The non-randomised registry comprised 61 patients who underwent organ preservation and seven who underwent radical surgery. Non-randomised patients who underwent organ preservation were older than randomised patients and more likely to have life-limiting comorbidities. Serious adverse events occurred in ten (16%) of 61 non-randomised patients who underwent organ preservation versus one (14%) of seven who underwent total mesorectal excision. 24 (39%) of 61 non-randomised patients who underwent organ preservation had high-risk histopathological features, while 25 (41%) of 61 achieved a complete response. Overall, organ preservation was achieved in 19 (70%) of 27 randomised patients and 56 (92%) of 61 non-randomised patients. Interpretation Short-course radiotherapy followed by transanal endoscopic microsurgery achieves high levels of organ preservation, with relatively low morbidity and indications of improved quality of life. These data support the use of organ preservation for patients considered unsuitable for primary total mesorectal excision due to the short-term risks associated with this surgery, and support further evaluation of short-course radiotherapy to achieve organ preservation in patients considered fit for total mesorectal excision. Larger randomised studies, such as the ongoing

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(20)30333-2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 197

Metadata

Authors
Bach, S. P., Gilbert, A., Brock, K., Korsgen, S., Geh, I., Hill, J., Gill, T., Hainsworth, P., Tutton, M. G., Khan, J., Robinson, J., Steward, M., Cunningham, C., Levy, B., Beveridge, A., Handley, K., Kaur, M., Marchevsky, N., Magill, L., Russell, A., Quirke, P., West, N. P., Sebag-Montefiore, D., Brown, G., Antonio, P., Vince, A., Hilken, N., Sidile, C., Wilcockson, A., Peto, R., Crosby, T., Moran, B., Olliff, J., Ashok, K., Slawik, S., Smethurst, A., Sripadam, R., Tagore, V., Terlizzo, M., Philip, B., Davies, R., Dodd, S., Essapen, S., Nisar, P., Stewart, A., Trickett, J., Ashish, B., Billings, P., Chandran, P., Corr, C., Favill, E., Gollins, S., Marsh, P., Maw, A., Neupane, R., Rajagopal, R., Cooper, R., Griffith, J., Hatfield, P., Lowe, A., Ostrowski, J., Robinson, J., Simpson, R., Adams, R., Bleehen, R., Davies, M., Morgan, M., Boone, D., Lacey, N., Seddon, I., Sizer, B., Stunell, H., Wu, S., Hadaki, M., Blunt, D., Cleator, S., Darzi, A., Goldin, R., Ziprin, P., Dobson, M., Pitt, M., Susnerwala, S., Williamson, D., Howarth, G., Lee, S., Wright, P., Hoare, T., Horgan, A., McDonald, F., Needham, S., Scott, J., Simmons, T., Biswas, D., Hernon, J., Kapur, G., Kapur, S., Sington, J., Speakman, C., Stebbings, W., Williams, S., Adusumalli, M., Agarwal, A., Borowski, D., Garg, D., Gill, T., Hegab, M., Hobday, C., Rao, V., Shrimankar, J., Tabaqchali, M., Wilson, D., Jones, O., Mortensen, N., Slater, A., Szuts, A., Wang, L., Warren, B., Weaver, A., Ahmad, M., Alexander, J., Flubacher, M., Tarver, D., Baluch, S., Beable, R., Cowlishaw, D., Higginson, A., Vogiatzis, P., Cruickshank, N., Joy, H., Peake, D., Zanetto, U., Saunders, M., Sun-Myint, A., Sripadam, R., Cooper, R., Hatfield, P., Teo, M., Allan, A., Geh, I., Glaholm, J., Goldstein, M., Hejmadi, R., Langman, G., Morton, D., Nelson, C., Tattersall, D., Falk, S., Longman, R., Roach, H., Shabbir, J., Shelley-Fraser, G., Thomas, M., Cripps, N., Haba, Y., Harris, G., Hookway, M., Simson, J., Skull, A., & Umar, T.
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2021-02
Volume
6
Issue
2
Pages
92-105
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W3111175770
Cited by
197
References
2
FWCI
7.30
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. https://app.cochat.ai/papers/10.1016/s2468-1253(20)30333-2
The paper
Bach, S. P., Gilbert, A., Brock, K., Korsgen, S., Geh, I., Hill, J., Gill, T., Hainsworth, P., Tutton, M. G., Khan, J., Robinson, J., Steward, M., Cunningham, C., Levy, B., Beveridge, A., Handley, K., Kaur, M., Marchevsky, N., Magill, L., . . . Umar, T. (2021). Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(20)30333-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.